Seelaus Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $374K | Sell |
746
-1,363
| -65% | -$654K | 0.26% | 117 |
|
|
2026
Q1 | $1.04M | Buy |
2,109
+392
| +23% | +$213K | 0.75% | 29 |
|
|
2025
Q4 | $995K | Buy |
1,717
+50
| +3% | +$28.3K | 0.79% | 31 |
|
|
2025
Q3 | $809K | Buy |
1,667
+1
| +0.1% | +$465 | 0.64% | 39 |
|
|
2025
Q2 | $676K | Hold |
1,666
| – | – | 0.6% | 46 |
|
|
2025
Q1 | $829K | Sell |
1,666
-125
| -7% | -$67.7K | 0.79% | 31 |
|
|
2024
Q4 | $932K | Hold |
1,791
| – | – | 0.85% | 22 |
|
|
2024
Q3 | $1.11M | Sell |
1,791
-75
| -4% | -$44.4K | 1.01% | 17 |
|
|
2024
Q2 | $1.03M | Hold |
1,866
| – | – | 1.05% | 17 |
|
|
2024
Q1 | $1.08M | Sell |
1,866
-98
| -5% | -$55K | 1.08% | 14 |
|
|
2023
Q4 | $1.04M | Sell |
1,964
-151
| -7% | -$73.1K | 1.01% | 14 |
|
|
2023
Q3 | $1.07M | Sell |
2,115
-405
| -16% | -$216K | 1.22% | 14 |
|
|
2023
Q2 | $1.31M | Sell |
2,520
-642
| -20% | -$346K | 1.03% | 16 |
|
|
2023
Q1 | $1.85M | Sell |
3,162
-1,235
| -28% | -$696K | 1.39% | 12 |
|
|
2022
Q4 | $2.42M | Sell |
4,397
-203
| -4% | -$108K | 1.81% | 7 |
|
|
2022
Q3 | $2.33M | Buy |
4,600
+46
| +1% | +$25.7K | 1.85% | 6 |
|
|
2022
Q2 | $2.47M | Sell |
4,554
-105
| -2% | -$57.8K | 1.84% | 7 |
|
|
2022
Q1 | $2.75M | Sell |
4,659
-390
| -8% | -$224K | 1.63% | 6 |
|
|
2021
Q4 | $3.37M | Sell |
5,049
-50
| -1% | -$31.2K | 1.83% | 7 |
|
|
2021
Q3 | $2.91M | Hold |
5,099
| – | – | 1.7% | 7 |
|
|
2021
Q2 | $2.57M | Buy |
5,099
+449
| +10% | +$212K | 1.5% | 9 |
|
|
2021
Q1 | $2.12M | Buy |
4,650
+460
| +11% | +$220K | 1.36% | 10 |
|
|
2020
Q4 | $1.95M | Sell |
4,190
-812
| -16% | -$381K | 1.42% | 10 |
|
|
2020
Q3 | $2.21M | Sell |
5,002
-300
| -6% | -$124K | 1.78% | 8 |
|
|
2020
Q2 | $1.92M | Buy |
5,302
+9
| +0.2% | +$3.02K | 1.75% | 10 |
|
|
2020
Q1 | $1.5M | Sell |
5,293
-25
| -0.5% | -$7.88K | 1.78% | 9 |
|
|
2019
Q4 | $1.73M | Hold |
5,318
| – | – | 1.4% | 11 |
|
|
2019
Q3 | $1.55M | Hold |
5,318
| – | – | 1.35% | 15 |
|
|
2019
Q2 | $1.56M | Sell |
5,318
-50
| -0.9% | -$13.8K | 1.41% | 12 |
|
|
2019
Q1 | $1.47M | Hold |
5,368
| – | – | 1.36% | 11 |
|
|
2018
Q4 | $1.2M | Hold |
5,368
| – | – | 1.29% | 23 |
|
|
2018
Q3 | $1.31M | Hold |
5,368
| – | – | 1.08% | 26 |
|
|
2018
Q2 | $1.11M | Sell |
5,368
-50
| -0.9% | -$10.6K | 0.97% | 37 |
|
|
2018
Q1 | $1.12M | Buy |
5,418
+568
| +12% | +$119K | 0.96% | 35 |
|
|
2017
Q4 | $921K | Buy |
+4,850
| New | +$929K | 0.8% | 45 |
|
Other funds holding TMO
RG
ECSS
LT
Seelaus Asset Management's TMO Position: Q2 2026 in Review
Seelaus Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 65% in Q2 2026, selling an estimated $654K and leaving 746 shares worth $374K. The position accounts for 0.26% of the portfolio, ranked #117.
Seelaus Asset Management first reported a position in TMO in Q4 2017 and has held it in 35 quarters since. The position peaked at $3.37M in Q4 2021. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Seelaus Asset Management held 746 shares of Thermo Fisher Scientific worth $374K as of Q2 2026.
- Seelaus Asset Management sold 1,363 Thermo Fisher Scientific shares in Q2 2026, an estimated $654K.
- Thermo Fisher Scientific made up 0.26% of Seelaus Asset Management's portfolio in Q2 2026, its #117 holding.
- Seelaus Asset Management first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 35 quarters since.
- Seelaus Asset Management's Thermo Fisher Scientific position peaked at $3.37M in Q4 2021.
- 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Seelaus Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.